Therefore, the aim of this study is to evaluate the expression pattern of four interleukins genes; IL-12A, IL-12B, IL-23A, and IL-27 in IBD patients and compared their levels in the remission and active phases. The gene discussed is IL12A; the disease is inflammatory bowel disease.